AMWatch

Innovationsfonden retter investeringer mod "transformerende" trend i medicinalsektoren

En ny, tre-årig investeringsstrategi fra Innovationsfonden skal understøtte strømning i sundheds- og medicinalsektoren mod mere individualiseret sygdomsbehandling.

En fundamental forandring er på vej i sundhedssektoren, hvor patienter frem for at modtage en standardbehandling i højere grad end tidligere vil blive tilbudt medicinsk behandling valgt på baggrund af den enkeltes biologiske karakteristika.

Behandlingstrategien - der er kendt som personlig eller præcisionsmedicin - har i forvejen regeringens og sundhedsvæsnets opmærksomhed, og nu melder også Innovationsfonden sig på banen med en tre-årig strategi for investeringer i projekter, der skal skabe fremdrift i udviklingen af mere målrettede behandlinger.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Danish FSA issues warning over SFDR implementation

The Danish FSA, Finanstilsynet, states that asset managers are using the EU’s sustainable finance disclosure regulation to signify quality, which is not the point of the legislation. In fact, the FSA states it is the opposite of what the EU intended.

Latest news

AMWatch job

See all jobs

See all jobs

Watch job

See all jobs

See all jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch